Published onSeptember 7, 2024GLP-1 Medications: Reshaping Healthcare Economics and Corporate Strategyhealthcareeconomicscorporate-strategyGLP-1An analysis of how GLP-1 receptor agonists are transforming the treatment of obesity and diabetes, while posing new challenges for healthcare economics and corporate strategy.
